Specialty
Aesthetics Cardiology Cataract & Refractive Dermatology General Ophthalmology Glaucoma Neuro-Ophthalmology Oculoplastics Optometry Retina Women's Health View All Courses
Course Type
Evaluation Supplement Multimedia Webinar Podcast In-Person Multi-part Collection
Search
Login

Best Practices in Presbyopia: Current and Future Management

By: Mile Brujic, OD, FAAO; Daniel H. Chang, MD; Marjan Farid, MD; Ian Benjamin Gaddie, OD, FAAO; Milton M. Hom, OD, FAAO; Francis S. Mah, MD; and Selina R. McGee, OD, FAAO

This course has expired. You can still review the content but course credit is no longer available.

Supplement Credits: 1

This continuing medical education (CME/CE) activity captures content from two webinars.

ACTIVITY DESCRIPTION
Emerging pharmaceutical options for the treatment of individuals with presbyopia are poised to enter the eye care landscape. This novel approach represents a completely new paradigm for eye care providers to consider when discussing the array of options available with patients.

TARGET AUDIENCE
This certified CE/CME activity is designed for optometrists and ophthalmologists who care for patients with presbyopia.

Expiration Date: Monday, February 28, 2022
Release Date: February 22, 2021

This independent educational activity is supported by an unrestricted educational grant from Allergan.

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Define the underlying mechanisms of presbyopic changes.
  • Interpret the clinical trial experience published in the literature with pharmaceutical and nonpharmaceutical presbyopia-correcting (PC) options.
  • Differentiate among the pharmacological properties of newly emerging presbyopia correcting drops and their mechanisms of action.
  • Explain how PC drops are likely to affect categories of patients based on individual characteristics.
  • Compare the side effects of pharmaceutical approaches to presbyopia correction with other treatment options to debate the pros and cons of each strategy.

Accreditation and Designation Statement

Provided by Evolve Medical Education, LLC

Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Evolve Medical Education designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Evolve Medical Education LLC (Evolve) is an approved COPE administrator.
Supported by State University of New York College of Optometr.

COPE Approved for 1 credit hour.
Course ID: 71282-PH
Activity ID: 121122

Participation Method

TO OBTAIN CREDIT
To obtain credit for this activity, you must read the activity in its entirety and complete the Pretest/Posttest/Activity Evaluation/Satisfaction Measures Form, which consists of a series of multiple-choice questions.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS

Hardware Requirements:
4GB+ RAM

Recommended internet speed 5Mbps+

 

Faculty and Disclosures


Milton M. Hom, OD, FAAO
Program Co-Chair
Private Practice
Azusa, CA

 


Francis S. Mah, MD
Program Co-Chair
Director, Cornea and External Disease
Co-Director, Refractive Surgery
Scripps Clinic
La Jolla, CA

 


Mile Brujic, OD, FAAO
Partner, Premier Vision Group
Bowling Green, OH

 


Daniel H. Chang, MD
Cataract and Refractive Surgeon
Clinical Research Director
Empire Eye and Laser Center
Bakersfield, CA

 


Marjan Farid, MD
Professor of Ophthalmology
School of Medicine
Vice Chair, Ophthalmic Faculty
Director, Cornea/External Disease, Cataract,
and Refractive Surgery
Gavin Herbert Eye Institute
University of California, Irvine
Irvine, CA

 


Ian Benjamin Gaddie, OD, FAAO
Owner and Director
Gaddie Eye Centers
Louisville, KY

 


Selina R. McGee, OD, FAAO
Founder Precision Vision of Edmond
Edmond, Oklahoma
Adjunct Assistant Professor
Northeastern State University College of Optometry
Tahlequah, OK

 

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests.
Mile Brujic, OD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Akorn, Alcon Vision, Allergan, Bausch + Lomb Health, Blephex, Contamac, CSEye, Eyevance, Horizon Therapeutics, Kala, Novartis, Sun Pharma, VMax Vision, and Zea Vision. Speaker's Bureau: Allergan, Bausch + Lomb Health, Kala, Novartis, Optovue, Sun Pharma, Zea Vision. Research: Contamac.

Daniel H. Chang, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Carl Zeiss Meditec, Johnson & Johnson Vision, Mynosys, and Omega Ophthalmics. Grant/Research Support: Acufocus, Johnson & Johnson Vision, and Mynosys. Stock/Shareholder: Omega Ophthalmics.

Marjan Farid, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Bio-Tissue, CorneaGen, Dompé, EyePoint, Eyevance, Johnson & Johnson Vision, Kala, Orasis, and Shire.

Ian Benjamin Gaddie, OD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant and Speaker’s Bureau: Aerie, Allergan, Bausch & Lomb, Ivantis, Novartis, and Sight Sciences. Grant/Research Support: Aerie. Stock/Shareholder: Tarsus, and Leo Lens.

Milton M. Hom, OD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant and Grant/Research Support: Allergan, Eyenovia, and Novartis. Speaker’s Bureau: Allergan.

Francis S. Mah, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, Bausch + Lomb, Eyenovia, Glaukos, iView, Johnson & Johnson Vision, Nevakar, Novartis, Ocular Science, and RxSight.

Selina R. McGee, OD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Cynosure, Dompe, Eyevance, Horizon, Kala, Lumenis, Novartis, Optovue, Versant, Vertical. Speaker’s Bureau: Allergan, Lumenis, and Optovue.

The Evolve staff and planners have no financial relationships with commercial interests. Conni Koury, writer, and Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Cataract & Refractive Surgery Today, Modern Optometry, or Allergan.

Begin Course